Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
Company Provides Update on FDA Approval of EXPARELâ„¢ and Commercial Strategy PARSIPPANY, N.J., Oct. 31, 2011 (CRWENEWSWIRE) -- Pacira Pharmaceuticals, Inc. (Nasdaq:PCRX), an emerging spec... [Read more]


